Skip to main content
Fig. 6 | BMC Complementary Medicine and Therapies

Fig. 6

From: Inhibition of IL-17 signaling in macrophages underlies the anti-arthritic effects of halofuginone hydrobromide: Network pharmacology, molecular docking, and experimental validation

Fig. 6

Cell viability of macrophages and activated macrophages were validated in vitro. (A) Cytotoxicity assay of macrophages with different concentrations of HF (0, 2, or 4 nM) for 24 h (n = 3 per group). (B) Effect of different concentrations of HF (0, 2, or 4 nM) on the viability of activated macrophages after co-incubation for 24 h (n = 3 per group). The data are represented as the means ± SD; * p < 0.05, ** p < 0.01

Back to article page